Total Clarity Wealth Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Total Clarity Wealth Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,000	Closed	-$2K	–	1029
2022 Q2	$2K	Buy	+3,000	New	+$2.3K	﹤0.01%	950
2022 Q1	–	Sell	-3,000	Closed	-$7K	–	972
2021 Q4	$7K	Buy	3,000 +1,000	+50%	+$2.51K	﹤0.01%	769
2021 Q3	$7K	Buy	+2,000	New	+$6.17K	﹤0.01%	768
2021 Q2	–	Sell	-2,000	Closed	-$6K	–	797
2021 Q1	$6K	Buy	+2,000	New	+$6.67K	﹤0.01%	671

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

MIAN

Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Total Clarity Wealth Management's INFI Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022, closing a stake of 3,000 shares — an estimated $2K sold.

Total Clarity Wealth Management first reported a position in INFI in Q1 2021 and held it in 4 quarters. The position peaked at $7K in Q4 2021. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

Total Clarity Wealth Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 3,000 Infinity Pharmaceuticals, Inc. shares in Q3 2022, an estimated $2K.
Total Clarity Wealth Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 4 quarters.
Total Clarity Wealth Management's Infinity Pharmaceuticals, Inc. position peaked at $7K in Q4 2021.
76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.